title: Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program.
abstract: An estimated two billion persons are latently infected with Mycobacterium tuberculosis. The host factors that initiate and maintain this latent state and the mechanisms by which M. tuberculosis survives within latent lesions are compelling but unanswered questions. One such host factor may be nitric oxide (NO), a product of activated macrophages that exhibits antimycobacterial properties. Evidence for the possible significance of NO comes from murine models of tuberculosis showing progressive infection in animals unable to produce the inducible isoform of NO synthase and in animals treated with a NO synthase inhibitor. Here, we show that O2 and low, nontoxic concentrations of NO competitively modulate the expression of a 48-gene regulon, which is expressed in vivo and prepares bacilli for survival during long periods of in vitro dormancy. NO was found to reversibly inhibit aerobic respiration and growth. A heme-containing enzyme, possibly the terminal oxidase in the respiratory pathway, likely senses and integrates NO and O2 levels and signals the regulon. These data lead to a model postulating that, within granulomas, inhibition of respiration by NO production and O2 limitation constrains M. tuberculosis replication rates in persons with latent tuberculosis.
authors.affiliation: Beckman Center, Rm. 241, Stanford Medical School, Stanford, CA 94305, USA.
authors.forename: Martin I
authors.initials: MI
authors.lastname: Voskuil
authors.forename: Dirk
authors.initials: D
authors.lastname: Schnappinger
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Visconti
authors.forename: Maria I
authors.initials: MI
authors.lastname: Harrell
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Dolganov
authors.forename: David R
authors.initials: DR
authors.lastname: Sherman
authors.forename: Gary K
authors.initials: GK
authors.lastname: Schoolnik
mesh_terms: D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D009569:Nitric Oxide / Q000502:physiology*; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects*; D014226:Triazenes / Q000494:pharmacology*
chemical_list: C105351:1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene; D020030:Nitric Oxide Donors; D014226:Triazenes; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase